It's good to have Swift as interim CEO and President. It would be even better to have a seasoned CEO who's track record and reputation as a CEO of a biotechnology company is well recognized. I think this should be next frontier.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.